FILE: The vaccine against the coronavirus disease developed by the Gamaleya Research Institute of Epidemiology and Microbiology. JOHANNESBURG -Johnson & Johnson has submitted applications for emergency use of its Covid-19 vaccine in South Africa. It could get the green light in the next few days. READ: J&J vaccine will prevent severe illness: Prof. Glenda Gray Meanwhile, the head of the Ministerial Advisory Council on Vaccines, Professor Barry Schoub, says they may consider suspending the rollout of the AstraZeneca vaccine. That's after a Wits University study found that this vaccine appears to be less effective against the variant of the virus discovered in South Africa.